ACTIVITY IN THE THIRD QUARTER OF 2013
ACTIVITY IN THE THIRD QUARTER OF 2013
(Unaudited data)
CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2013
thousands of euros
2012
2013
Variation at current exchange rates
Variation at constant exchange rates
France
233,426
252,193
+ 8.0%
+ 8.0%
International :
165,959
193,077
+ 16.3%
+ 18.4%
Incl. Europe excluding France
126,041
144,637
+ 14.8%
+ 16.3%
Incl. North America
31,282
37,732
+ 20.6%
+ 24.4%
Incl. Other countries
8,636
10,708
+ 24.0%
+ 27.4%
Group Total
399,385
445,270
+ 11.5%
+ 12.3%
thousands of euros
2012
2013
Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines
213,592
225,694
+ 5.7%
+ 5.9%
OTC Specialties
185,394
219,279
+ 18.3%
+ 19.9%
Other
399
297
- 25.6%
- 29.1%
Group Total
399,385
445,270
+ 11.5%
+ 12.3%
DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
thousands of euros
1st Quarter
2nd Quarter
3rd Quarter
2012
2013
Var.
13/12
2012
2013
Var.
13/12
2012
2013
Var.
13/12
France
74,188
84,270
+ 13.6%
71,210
75,327
+ 5.8%
88,028
92,596
+ 5.2%
International :
54,904
73,751
+ 34.3%
41,216
42,436
+ 3.0%
69,839
76,890
+ 10.1%
Incl. Europe excluding France
41,807
54,334
+ 30.0%
28,889
29,047
+ 0.5%
55,345
61,256
+ 10.7%
Incl. North America
10,285
15,562
+ 51.3%
9,861
10,017
+ 1.6%
11,136
12,153
+ 9.1%
Incl. Other countries
2,812
3,855
+ 37.1%
2,466
3,372
+ 36.7%
3,358
3,481
+ 3.7%
Group Total
129,092
158,021
+ 22.4%
112,426
117,763
+ 4.7%
157,867
169,486
+ 7.4%
thousands of euros
1st Quarter
2nd Quarter
3rd Quarter
2012
2013
Var.
13/12
2012
2013
Var.
13/12
2012
2013
Var.
13/12
Non-proprietary Homeopathic Medicines
73,427
79,062
+ 7.7%
70,206
73,035
+ 4.0%
69,959
73,597
+ 5.2%
OTC Specialties
55,576
78,866
+ 41.9%
42,007
44,600
+ 6.2%
87,811
95,813
+ 9.1%
Other
89
93
+ 4.5%
213
128
- 39.9%
97
76
- 21.6%
Group Total
129,092
158,021
+ 22.4%
112,426
117,763
+ 4.7%
157,867
169,486
+ 7.4%
HIGHLIGHTS OF THE THIRD QUARTER
Sales revenue in the third quarter 2013 grew by 7.4% compared to 2012 (8.9% at constant rates).
The increase is due to the sales:
of Non-proprietary Homeopathic Medicines, in particular in France, Italy and the USA.
of winter Specialties, in particular in France, Italy and Russia.
On September 30, 2013, the group cash balance amounted €116.4 million versus €94.7 million on December 31, 2012.
OUTLOOK
Considering this performance, Boiron confirms its target of further increases of its business and profitability in 2013.
Our next update: January 23, 2014 at market close, publication of the sales revenue for the year 2013.
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-33859-cp_boiron-241013.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Source: Actusnews